Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
about
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
description
scientific article published on 04 November 2019
@en
name
Clinical efficacy and biomarke ...... carcinoma in the ABACUS trial
@en
type
label
Clinical efficacy and biomarke ...... carcinoma in the ABACUS trial
@en
prefLabel
Clinical efficacy and biomarke ...... carcinoma in the ABACUS trial
@en
P2093
P50
P1433
P1476
Clinical efficacy and biomarke ...... carcinoma in the ABACUS trial
@en
P2093
Alain Ravaud
Albert Font Pous
Alejo Rodriguez-Vida
Bernadett Szabados
Cristina Suarez
Daniel Castellano
Denis Maillet
Diana Stanoeva
Gwenaelle Gravis
Ignacio Duran
P304
P356
10.1038/S41591-019-0628-7
P50
P577
2019-11-04T00:00:00Z